Ellie Mae (ELLI): Notes From the Road - Needham

Needham & Company analyst, Mayank Tandon, reiterated his Buy rating on shares of Ellie Mae (NYSE: ELLI) after hosting company management on a non deal roadshow in Chicago.

The analyst has increased confidence that the company will continue to penetrate the large TAM, and robust multi-year revenue growth and margin expansion opportunities. ELLI continues to outperform expectations fueled by multiple growth drivers such as compliance resulting from changing regulations, automation of the loan origination process, and success in penetrating the enterprise market.

The “operating” assumptions are unchanged but the analyst cut EPS estimates to reflect the recent follow-on offering. No change to the price target of $125.

For an analyst ratings summary and ratings history on Ellie Mae click here. For more ratings news on Ellie Mae click here.

Shares of Ellie Mae closed at $96.63 yesterday.

You May Also Be Interested In

• META to capture largest share of users, SNAP to benefit from ad budget shifts - Canaccord Genuity weighs in on TikTok ban
• Cidara Therapeutics (CDTX) PT Raised to $25 at Needham
• Acrivon Therapeutics Inc (ACRV) PT Lowered to $22 at Jones Trading